Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. Added

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool as read-only, open-world, and idempotent, and the description adds substantial behavioral context: it fans out across multiple sources, returns sources_used/sources_failed, treats an empty section as real 'no data', soft-fails the USPTO patent source, and explains the FDA products section can be empty for non-biologics companies. This gives an agent clear expectations about partial results and fallbacks.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but information-dense; it front-loads the most important usage instruction and then packs the return shape, fallback behavior, and accepted input shapes into a compact set of clauses. A cleaner list structure might improve scanability, but nearly every sentence carries unique decision-relevant content.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries full responsibility for explaining what the tool returns, and it does: it enumerates all main response sections (CIK, recent filings, fundamentals, patents, federal contracts, FDA products, H-1B, news, LEI), explains sources_used/sources_failed semantics, and covers empty-result expectations and the resolved:false private-company case. Nothing an agent needs to invoke or interpret this tool correctly is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already documents both parameters at 100% coverage, and the description adds extra meaning: it gives concrete examples for type and value, clarifies that 'company' and 'ticker' are interchangeable, and describes name resolution through SEC EDGAR plus the private-company resolved:false outcome. This goes well beyond the schema's raw enum and string descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description names a specific verb and resource: it says it produces a 'full cross-source profile of a US public company' in one parallel call, and gives concrete invocation phrasings. It also distinguishes this from single-pack SEC/XBRL/news lookups by explicitly saying to prefer it for holistic-view requests.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly states when to use this tool: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also clarifies edge-case usage behavior for private companies (returns resolved:false with an explicit notes line) and how to pass names, tickers, and CIKs.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.4/5.0
Disambiguation2/5

The tool set is a mix of country lookups and many unrelated Pipeworx tools (e.g., prediction markets, memory, subscriptions). While the country-specific tools are distinct, the overall set is a hodgepodge, making it difficult for an agent to determine which tools are relevant to a given task.

Naming Consistency2/5

Naming conventions are mixed: some use verb_noun (search_countries), some noun_verb (countries_by_currency), some single verbs (forget, recall), and some phrases (ai_visibility_check, ask_pipeworx). No consistent pattern is followed.

Tool Count1/5

35 tools is excessive for a server named 'countries'. Only about 6-7 tools are actually related to countries; the rest are unrelated (Pipeworx services, prediction markets, etc.), creating an extreme mismatch between the server name and its content.

Completeness2/5

For the country domain, the tool set includes search and lookups by code/currency/language/region but lacks basic CRUD, comparisons, maps, or sorting. Additionally, the presence of many unrelated tools dilutes completeness for the stated purpose.